(Q34455748)

2 August 2017

title

Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

2 August 2017

main subject

0 references

author name string

Isao Nagano

1

1 reference

2 August 2017

Mito Shiote

2

1 reference

2 August 2017

Tetsuro Murakami

3

1 reference

2 August 2017

Hiroshi Kamada

4

1 reference

2 August 2017

Yoshiyuki Hamakawa

5

1 reference

2 August 2017

Etsuro Matsubara

6

1 reference

2 August 2017

Masataka Yokoyama

7

1 reference

2 August 2017

Kiyoshi Moritaz

8

1 reference

2 August 2017

Mikio Shoji

9

1 reference

2 August 2017

Koji Abe

10

1 reference

2 August 2017

language of work or name

1 reference

1 October 2005

1 reference

2 August 2017

published in

Neurological Research

1 reference

2 August 2017

volume

27

1 reference

2 August 2017

issue

7

1 reference

2 August 2017

page(s)

768-772

1 reference

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Involvement of protein kinase C and nitric oxide in the modulation by insulin-like growth factor-I of glutamate-induced GABA release in the cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164105X39860

21 January 2018

Identifiers

DOI

10.1179/016164105X39860

1 reference

2 August 2017

1 reference